Global law firm Norton Rose Fulbright has advised Resource Capital Funds on the acquisition of Cobre Las Cruces, owner of the Las Cruces copper mine in Spain, from First Quantum Minerals.

Global law firm Norton Rose Fulbright is advising Jiangxi Copper Investment Company Ltd (Jiangxi Copper) on its £842 million acquisition of SolGold plc.

In October 2025, the Supreme Court of Appeal held that an attorney and conveyancer acting exclusively for a developer in a complex property transaction is not delictually liable to other parties, who were not the attorney’s clients, for not warning them against the risks of the transaction.

Global law firm Norton Rose Fulbright is pleased to announce that Jason Chan has joined the firm as a partner in its Hong Kong office.

Global law firm Norton Rose Fulbright has further strengthened its global aviation practice with the appointment of leading aviation finance partner Leo Fattorini as its Head of Aircraft Finance, Asia and the Middle East, based in Singapore. 

Norton Rose Fulbright partners Reagan Brown and Andrew Giaccia have been inducted into Lawdragon’s 2026 Hall of Fame.

In this issue of Regulation Around the World we look at some of the key regulatory topics for 2026 in the following jurisdictions

As far as the Mergers and Acquisitions (M&A) market is concerned, 2025 turned out to be a tale of two halves. The year began very positively with a downward trajectory in inflation and interest rates expected throughout 2025, and a pro-business deregulatory stance anticipated in the US under the second Trump presidency.

The two-component tariff has been mandated in Vietnam pursuant to Article 50 of the amended Electricity Law 2024 and Government Decree 146/2025/ NĐ-CP.

Since the 2024 amendments to Ontario’s Construction Act under Schedule 4 of Bill 216 (Building Ontario For You Act (Budget Measures), 2024) received royal assent, project owners and construction companies have been holding their breath for the amendments to come into force.

The Sustainable Harnessing and Advancement of Nuclear Energy Act, 2025 (the SHANTI Act) came into effect in India on 21 December 2025. The SHANTI Act is the most sweeping reform of India’s nuclear regime to date, repealing the previously existing Atomic Energy Act, 1962 and the Civil Liability for Nuclear Damage Act, 2010 (CLND Act).

2025 marked a turning point for UK private equity, and as we look to 2026, industry participants anticipate a further uptick in deal activity, particularly in the mid-market, but caution remains essential as competition intensifies and regulatory scrutiny grows.

The Supreme Court of British Columbia recently released its decision in 1154557 B.C. Limited v. Skychain Technologies Inc., a case in which the court addressed the invalidation of shareholder proxies in connection with a contested annual general meeting, and provided guidance on interpreting advance notice provisions in company articles or by-laws

In this article we look at key regulatory topics for 2026 that will have a significant impact on institutions operating in the UK financial services space. We have not attempted to list every single reform expected next year but rather pick out those with the potential to be most significant, as well as the key regulatory enforcement developments.

The USPTO has retooled its examination pilots, impacting nuanced filing strategy and timing.

Norton Rose Fulbright advises Lantmännen Energi AB on strategic acquisition of Ekobenz

Global law firm Norton Rose Fulbright has advised a consortium of Polish financial institutions, comprising mBank and Bank Ochrony Środowiska, on a long-term refinancing facility of PLN 227 million (EUR 53.5 million) granted to special purpose vehicles controlled by Atsinaujinančios Energetikos Investicijos, a closed-end investment fund managed by Lords LB Asset Management.

Is a document production order issued by a foreign court sufficient to ground authorization by a Canadian securities commission to release relevant but confidential commission investigation records?

Global law firm Norton Rose Fulbright has advised ZPUE S.A., a subsidiary of the Koronea Family Office, on the acquisition of BWTS GmbH from its previous shareholders.

Global law firm Norton Rose Fulbright advises Zydus Lifesciences Global FZE (Zydus) on its strategic partnership with Formycon AG (Formycon) for the exclusive licensing and supply of FYB206, a biosimilar to a major humanized monoclonal antibody in the field of oncology (Reference Product), in the United States and Canada.